Hemolytic Uremic Syndrome (HUS) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
Conditions: Thrombotic Microangiopathies; Atypical Hemolytic Uremic Syndrome Intervention: Biological: OMS721 Sponsor: Omeros Corporation Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2017 Category: Research Source Type: clinical trials
